...
首页> 外文期刊>Romanian Journal of Diabetes Nutrition and Metabolic Diseases >Assessment of Common Risk Factors and Lifestyle Habits Associated with Atherogenic Risk and Lipid-Lowering Therapy in Men with Type 2 Diabetes
【24h】

Assessment of Common Risk Factors and Lifestyle Habits Associated with Atherogenic Risk and Lipid-Lowering Therapy in Men with Type 2 Diabetes

机译:评估与2型糖尿病的男性患者患有动脉粥风险和脂质降低治疗的常见风险因素和生活方式习惯

获取原文
           

摘要

Background and aims: Our objective was to determine common risk factors and lifestyle habits associated with atherogenic risk and with the use of lipid-lowering therapy in men with type 2 diabetes. Material and Methods: A comparative cross-sectional study was performed in the northwestern Algeria during eleven months on adult men patients with type 2 diabetes. Anthropometric parameters, blood pressures and lipid profile were evaluated. Data of common risk factors and lifestyle habits associated to atherosclerosis were compared between two groups according to the lipid lowering therapy use based on statins. Results: 147 adult men patients with type 2 diabetes were involved in the study, 68 (46.26%) were under statins therapy and 79 (53.74%) were not. Significant associations with statins use were observed regarding the age group of 61-70 years (OR: 0.156 [0.043-0.570]; p=0.005), a salary of less than 30000 Algerian dinars (≈250.60$) (OR: 5.758 [1.299-25.512]; p=0.021), age of diabetes of 2-3 years (OR: 0.105 [0.013-0.867]; p=0.036) as well as with lipid ratios and body mass index (BMI). However, no significant associations were noted regarding the other studied parameters (marital status, educational level, occupation, salary, and family history, smoking status, alcohol consumption and sports practices) with lipid lowering therapy. Conclusion: Age of patients, diabetes duration, lipid ratios and the low income of patients are the strongest factors associated with the use of lipid lowering therapy (statins). However, largest longitudinal studies are needed to determine whether modifiable lifestyle habits could influence the lipid lowering therapies prescription in diabetic patients over time.
机译:背景和宗旨:我们的目标是确定与体育风险有关的共同危险因素和生活方式习惯,并在2型糖尿病中使用脂质降低治疗。材料和方法:在19个月的成人2型糖尿病患者的11个月内在阿尔及利亚西北部进行比较横截面研究。评价人体测量参数,血压和脂质谱。根据西汀蛋白的脂质降低治疗使用,比较了与动脉粥样硬化相关的常见风险因素和生活方式习惯。结果:147名成人男性患有2型糖尿病患者参与研究,68名(46.26%)在他汀类药物治疗下,79(53.74%)没有。观察到与他汀类药物使用的重要组织有关年龄组的61-70岁(或:0.156 [0.043-0.570]; P = 0.005),薪水少于30000阿尔及利亚第纳尔(≈250.60$)(或:5.758 [1.299] -25.512]; p = 0.021),糖尿病年龄为2-3岁(或:0.105 [0.013-0.867]; p = 0.036)以及脂质比和体重指数(BMI)。然而,没有关于其他研究参数(婚姻状况,教育水平,占用,工资和家族史,吸烟状态,酒精消费和体育习惯)没有重大协会。结论:患者年龄,糖尿病持续时间,脂质比率和患者的低收入是与使用脂质降低治疗(他汀类药物)相关的最强因素。然而,需要最大的纵向研究来确定可修改的生活方式习惯是否会随着时间的推移影响糖尿病患者的脂质降低治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号